RNA, U1 small nuclear 64, pseudogene (RNU1-64P)

**RNU1-64P (RNA, U1 small nuclear 64, pseudogene)** is classified as a *pseudogene* for the U1 small nuclear RNA (snRNA) family. The canonical U1 snRNA is a highly conserved, abundant noncoding RNA critical for pre-mRNA splicing as part of the spliceosome, but *pseudogenes* like RNU1-64P are generally non-functional genetic elements that arise from duplication or retrotransposition of U1 snRNA genes and typically have sequence defects, such as mutations or deletions, that prevent normal function[2][3]. Pseudogenes, by definition, do not encode proteins and typically do not produce functionally significant RNAs; however, some variant U1 snRNA pseudogenes may be transcribed and have unknown or minor roles in RNA biology, but no specific function has been established for RNU1-64P[2][3].\n\nRNU1-64P **is not a protein or a recognized drug target**, nor is it established as a biomarker, disease gene, or involved in any known pharmacological mechanism[2][3]. Its classification as a *pseudogene* means it does not have the biological activity attributed to canonical U1 snRNA, which is required for spliceosome assembly and mRNA processing[1][2][3]. There is no evidence that RNU1-64P itself participates in any normal or abnormal biological processes, nor is it a receptor, enzyme, or other molecular target for drugs. Therefore, **there is something structurally or functionally incorrect about treating RNU1-64P as a therapeutic target or receptor**[2][3].

Other names

RNU1-64PU1 snRNA pseudogene 64U1 small nuclear RNA pseudogene 64